| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Sales Management > US Trade Shows ARE Different - Notes for Foreign Firms |
|
Just Other Articles - US Trade Shows ARE Different - Notes for Foreign Firms
According to Julia O’Connor, president of Trade Show
Training, inc. (TSTi) there a According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product re three universal components to
any trade show, anywhere in the world – promotion ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in
presentation and logistics. "While it seems simple", she
said, "there are both lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. subtle and major differences in shows
in the US and other countries." Promotion - here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe marketing - is probably more universal,
especially now with the Internet, said O’C d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro onnor, but
presentation – the sales component – is more affected by
culture and ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc usiness expectations. "Americans are viewed as loud and aggressive. Even as we ex easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi pand globally, we understand we must be more
relationship-oriented. We find it har nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically to change but we try
to", O’Connor explained. The biggest challenge – and the mo and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ st complaints she
hears – are about the logistics component. It is the unions,
t ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi e transportation and shipping problems, the set-up and
tear-down. Many countries a ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a nd shows use a turnkey
operation. In the States, there are different unions to per dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod orm
services before, during and after a show. "It becomes confusing to individual cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin s and expensive for
companies that do not understand the process in the US,"
O’C tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen nnor said. Those companies planning to exhibit in the US, or those who currently t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel exhibit, often do not know where to turn for
assistance. Specialized seminars, run ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust as Camp
Sho-M-Sel-M, provide the information. Trade shows are complicated events y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products – short term with lots
of details. The process is complicated by language, culture . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
and old habits. The more a foreign firm knows about US
trade shows, the more suc elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip cessful they will be. ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Marketing a Private Practice: Mistake #1: Trying to Be All Things To All People How To Conduct A Successful Performance Appraisal
|